These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 30027840

  • 1. Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.
    Gelain A, Mori M, Meneghetti F, Villa S.
    Curr Med Chem; 2019; 26(27):5165-5206. PubMed ID: 30027840
    [Abstract] [Full Text] [Related]

  • 2. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
    Furtek SL, Backos DS, Matheson CJ, Reigan P.
    ACS Chem Biol; 2016 Feb 19; 11(2):308-18. PubMed ID: 26730496
    [Abstract] [Full Text] [Related]

  • 3. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.
    Dong J, Cheng XD, Zhang WD, Qin JJ.
    J Med Chem; 2021 Jul 08; 64(13):8884-8915. PubMed ID: 34170703
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
    Wang X, He Q, Wu K, Guo T, Du X, Zhang H, Fang L, Zheng N, Zhang Q, Ye F.
    Eur J Med Chem; 2019 Oct 01; 179():218-232. PubMed ID: 31254923
    [Abstract] [Full Text] [Related]

  • 5. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
    Huang Q, Zhong Y, Li B, Ouyang S, Deng L, Mo J, Shi S, Lv N, Wu R, Liu P, Hu W, Zhang X, Wang Y.
    Eur J Med Chem; 2021 Oct 05; 221():113525. PubMed ID: 34000483
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
    Huang W, Liu Y, Wang J, Yuan X, Jin HW, Zhang LR, Zhang JT, Liu ZM, Cui JR.
    Eur J Med Chem; 2018 Sep 05; 157():887-897. PubMed ID: 30145375
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin.
    Zhou Q, Zhu J, Chen J, Ji P, Qiao C.
    Bioorg Med Chem; 2018 Jan 01; 26(1):96-106. PubMed ID: 29174507
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M, Czerwoniec A, Wesoly J, Bluyssen HA.
    PLoS One; 2015 Jan 01; 10(2):e0116688. PubMed ID: 25710482
    [Abstract] [Full Text] [Related]

  • 12. Small molecule inhibitors of STAT3 for cancer therapy.
    Zhao M, Jiang B, Gao FH.
    Curr Med Chem; 2011 Jan 01; 18(26):4012-8. PubMed ID: 21824090
    [Abstract] [Full Text] [Related]

  • 13. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
    Martínez-García D, Pérez-Hernández M, Korrodi-Gregório L, Quesada R, Ramos R, Baixeras N, Pérez-Tomás R, Soto-Cerrato V.
    Biomolecules; 2019 Aug 13; 9(8):. PubMed ID: 31412593
    [Abstract] [Full Text] [Related]

  • 14. Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
    Kolosenko I, Yu Y, Busker S, Dyczynski M, Liu J, Haraldsson M, Palm Apergi C, Helleday T, Tamm KP, Page BDG, Grander D.
    PLoS One; 2017 Aug 13; 12(6):e0178844. PubMed ID: 28636670
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. STAT 3 as a target for cancer drug discovery.
    Costantino L, Barlocco D.
    Curr Med Chem; 2008 Aug 13; 15(9):834-43. PubMed ID: 18473793
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
    Huang Q, Zhong Y, Dong H, Zheng Q, Shi S, Zhu K, Qu X, Hu W, Zhang X, Wang Y.
    Eur J Med Chem; 2020 Feb 01; 187():111922. PubMed ID: 31810784
    [Abstract] [Full Text] [Related]

  • 20. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
    Huang TT, Su JC, Liu CY, Shiau CW, Chen KF.
    Int J Mol Sci; 2017 Jun 08; 18(6):. PubMed ID: 28594363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.